ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

DEBBRA BABIN FNP

At A Glance: This Prescriber in 2012

Nurse Practitioner

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,911Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 91

$362K Total Retail Price of All Prescriptions

Rank: 11 out of 91

430 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 430 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

8% of this provider’s 430 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 4,001 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $85 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
SIMVASTATIN 302 222 1 4
LISINOPRIL 290 196 2 1
ATENOLOL 238 191 3 13
LEVOTHYROXINE SODIUM 201 157 4 3
METOPROLOL TARTRATE 179 115 5 10
METFORMIN HCL 176 104 6 9
AMLODIPINE BESYLATE 156 123 7 11
OMEPRAZOLE 145 84 8 2
HYDROCHLOROTHIAZIDE 131 93 9 8
WARFARIN SODIUM 106 82 10 12
LOVASTATIN 102 85 11 25
ATORVASTATIN CALCIUM 90 62 12 16
HYDROCODONE-ACETAMINOPHEN 81 37 S3 13 5
GABAPENTIN 76 61 14 14
FUROSEMIDE 75 62 15 7
SERTRALINE HCL 73 43 16 15
ADVAIR DISKUS 71 52 17 22
PAROXETINE HCL 67 63 18 48
DIOVAN 66 59 19 55
TRAZODONE HCL 66 32 19 19
AZITHROMYCIN 64 38 21 51
PANTOPRAZOLE SODIUM 63 38 22 23
CITALOPRAM HBR 62 31 23 31
RANITIDINE HCL 61 33 24 17
CYCLOBENZAPRINE HCL 58 16 R 25 35
SPIRIVA 57 47 26 30
GLIPIZIDE 55 42 27 54
TRAMADOL HCL 54 22 28 32
TRICOR 53 41 29 126
PROAIR HFA 52 37 30 41
LOSARTAN POTASSIUM 51 47 31 68
METOPROLOL SUCCINATE 51 33 31 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 18, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.